CN Patent
CN108084067B — 一种立他司特中间体的制备方法
Assigned to Chongqing Chang Jie Pharmaceutical Co Ltd · Expires 2019-08-30 · 7y expired
What this patent protects
本发明属于药物化学技术领域,具体涉及一种立他司特中间体的制备方法。该方法包括碘代、偶联、水解三个步骤,得到L‑BOC‑间甲磺酰基丙氨酸。本发明所提供的方法,与现有合成方法相比,具有原料廉价易得、工艺简单、收率高等特点。
USPTO Abstract
本发明属于药物化学技术领域,具体涉及一种立他司特中间体的制备方法。该方法包括碘代、偶联、水解三个步骤,得到L‑BOC‑间甲磺酰基丙氨酸。本发明所提供的方法,与现有合成方法相比,具有原料廉价易得、工艺简单、收率高等特点。
Drugs covered by this patent
- Xiidra (LIFITEGRAST) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.